Normal scar tissue forms to heal an internal wound and quietly retreats when the job is done. But in many common diseases — kidney, liver and lung fibrosis — the scar tissue goes rogue and strangles vital organs. These diseases are largely untreatable and ultimately fatal.
A new Northwestern Medicine study has newly identified a trigger of some fibrotic diseases and an experimental compound to treat it.
Fibrosis — a progressive scarring and hardening of internal organs — is estimated to cause 35 to 40 percent of deaths in the world. Fibrotic diseases include diabetic kidney fibrosis, alcoholic liver cirrhosis, hepatitis C, pulmonary fibrosis and nonalcoholic fatty liver disease, which may lead to fibrosis of the liver, the leading cause of liver transplant.
In one subset of human fibrosis cells, scientists discovered a delinquent gang of molecules that continually shouted at an immune receptor — the antennae on the cell — to produce scar tissue instead of quieting down and allowing the scar tissue to go back to sleep.
Scientists collaborated with a University of Colorado researcher who used crystallography and computer modeling to predict a molecule that could block the receptor that leads to the uncontrolled scarring. When they tested the molecule, T53, in three different mouse models of fibrosis, the abnormality was significantly reversed.
“Our study opens a new door into fibrosis by looking at it as an aberrant innate immune response and suggesting a novel approach to treat it,” said senior author Dr. John Varga, director of the Northwestern Scleroderma Program and the John and Nancy Hughes Distinguished Professor of Rheumatology at Northwestern University Feinberg School of Medicine.
The paper was published July 12 in the Journal of Clinical Investigation Insight.
“The leading cause of liver failure in western world is obesity and that’s because of liver fibrosis,” Varga said. “In the U.S., many of these diseases are lifestyle or age dependent. As we get fatter or older, they get worse.”
Most fibrotic disease likely begins as normal repair of an injury, scientists said. “But if the immune system produces too much of an initial scar, it can’t go back to normal,” Varga said. “You have an unhealed scar that keeps growing and can wipe out the entire organ.”
Not everyone’s fibrosis is caused by the same abnormality, Varga said. If the compound, T53, is eventually developed into an approved drug, it would be targeted to patients with the specific genetic signature identified in the study.
“There is an emerging direction for treating fibrosis with precision medicine,” said first author Swati Bhattacharyya, research associate professor of medicine in rheumatology and scientific director of the Scleroderma Research Laboratory at Feinberg. “Some people live with fibrotic disease for 30 years while others die in two years. We need to identify the rapid progressors from the slow progressors. That’s where precision medicine becomes really critical.”
“The results of this study are encouraging,” Varga said. “We are not saying this compound is ready to be a drug. It’s an initial compound that would need to be developed and tweaked. It would need significant funding to go to the next step.”
Learn more: Why internal scars won’t stop growing
The Latest on: Fibrosis
via Google News
The Latest on: Fibrosis
Teen 'barred' from school trip of a lifetime for having cystic fibrosis
on July 18, 2018 at 4:34 am
Just a week before Jess Park-Davies' was due to fly to Iceland the school cancelled her ticket and said she could not go. A schoolgirl with cystic fibrosis has been 'barred' from going on a once -in-a ... […]
What is cystic fibrosis-related diabetes?
on July 18, 2018 at 1:08 am
Cystic fibrosis is an incurable genetic disease that affects around 70,000 people worldwide. A defective gene causes a build-up of mucus in the airwaves, making it increasingly difficult to breathe ov... […]
Cystic fibrosis teen 'barred' from going on once-in-a-lifetime school trip to Iceland leaving her in tears
on July 17, 2018 at 11:10 pm
A teenage girl with cystic fibrosis is devastated after she was 'barred' from going on a school trip to see Iceland's natural wonders, her mum says. Jess Park-Davies was excited to visit the island's ... […]
Schoolgirl with cystic fibrosis 'barred' from school trip
on July 17, 2018 at 9:54 pm
A schoolgirl with cystic fibrosis has been 'barred' from going on a once -in-a- lifetime school trip to Iceland. Jess Park-Davies was due to fly to the Icelandic capital of Reykjavik on Monday July 2 ... […]
Driscoll Children's Hospital to hold Cystic Fibrosis Family Day
on July 17, 2018 at 7:50 am
Those who live with Cystic Fibrosis (CF) can tell you how important the support of friends and family can be in dealing with the disease. CF affects the lungs and digestive system of about 30,000 chil... […]
U.K. health officials make a counteroffer to Vertex for its pricey cystic fibrosis drugs
on July 17, 2018 at 7:33 am
eeking to break a stalemate over pricey cystic fibrosis drugs, the U.K.’s National Health Service has offered Vertex Pharmaceuticals (VRTX) what it called the “largest ever financial commitment of its ... […]
Pliant Picks Up $62M to Test Lung, Liver Fibrosis Drug in the Clinic
on July 16, 2018 at 5:09 am
The cause of fibrosis, the hardening and thickening of connective tissue in organs, isn’t known and it has few treatments. Pliant Therapeutics aims to bring patients who have this chronic and life-thr... […]
Looking ahead to the CF Climb benefiting the Cystic Fibrosis Foundation
on July 15, 2018 at 6:04 pm
There's an organization close to Danielle Grant's heart - the Cystic Fibrosis Foundation - and they're holding the CF Climb soon. More info here: https://www.cff.org/PDF-Archive/Chapter-PDFs/CODN_Cale... […]
Parents Battle Officials As Siberian Kids With Cystic Fibrosis Face Infection Outbreak
on July 15, 2018 at 8:34 am
KEMEROVO, Russia -- For nearly two years, Natalya Drobysheva has been locked in a battle with local health authorities in this south-central Siberian city to obtain the medicine she believes could sav... […]
via Bing News